For Nvidia Stock, It’s Game On!

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

AI Becomes Silicon Valley’s Next Buzzy Bandwagon as Crypto Boom Fizzles

The new artificial-intelligence tools getting widespread attention for spitting out text, images and computer code are also generating something else: talk of the next technology bubble. Technologists...

Nvidia Stock Can Endure a Slowdown, Analyst Says. AI Is Key.

Nvidia should be insulated from any slowdown in the broader economy by increased spending on artificial intelligence, said analysts at Oppenheimer and KeyBanc, who lifted their price targets on shares...

AI is dominating the action in the stock market right now

OpenAI, the developer of ChatGPT, is receiving billions of dollars in funding from Microsoft Corp. MSFT, -0.20%. The rollout of this new technology has been followed by similar efforts by Alphabet Inc...

ChatGPT Has Sparked an AI Craze. How to Build a Long-Term AI Portfolio.

Artificial intelligence has sparked new competition in internet search—for the first time in decades. Here’s how to build an AI portfolio. Feb. 10, 2023 6:06 pm ET It has been more than 70 years...

Nvidia, Broadcom, and Marvell Are Chip Stocks to Benefit in AI Arms Race

J.P. Morgan says there are three semiconductor companies that will thrive from the rising demand for artificial-intelligence services and software. In a note to clients on Friday, analyst Harlan Sur s...

These 20 AI stocks are expected by analysts to rise up to 85% over the next year

There are always fads in the stock market, but now we are in the midst of what could turn out to be a revolutionary trend that will last much longer than any fad — artificial intelligence. In the Need...

AI Stocks Are Soaring. It’s a Feeding Frenzy That Won’t End Well.

Investors are in a feeding frenzy over artificial-intelligence software plays, and you have to think this isn’t going to end well. You can date the start of the AI stock craze to the Nov. 30 launch of...

C3.ai, BigBearAI, and SoundHound Stock Are Soaring in an AI Feeding Frenzy

Investors are in a feeding frenzy over artificial-intelligence software plays, and you have to think this isn’t going to end well. You can date the start of the AI stock craze to the Nov. 30 launch of...

Tech execs can’t stop talking about AI after success of ChatGPT

The pace of artificial-intelligence chatter from executives is picking up after the success of ChatGPT, and it isn’t all from Big Tech. Big Tech companies like Microsoft Corp., Meta Platforms Inc., an...

China’s Baidu Plans a ChatGPT Rival. The Internet Giant’s Stock Could Reap the Returns.

Talk about buying the rumor. Baidu China’s leading internet search provider, let it be known on Jan. 30 that it will launch a so-called chatbot powered by artificial intelligence, akin to the ChatGPT ...

C3.ai Stock Is Soaring. It’s Launching AI Software Tools.

C3.ai stock is soaring Tuesday after the company announced the launch of a set of tools for generative artificial intelligence applications, jumping into the middle of what might be the hottest trend ...

7 Cheap But Risky Biotech Stocks

Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%. The other most-watched exchange-traded fund that tracks the biotech sector, the...

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...

Why Pfizer Is Pulling Back on Research Into Rare Disease, Gene Therapy

Pfizer is planning to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies, the company told employees on Thursday afternoon...

The Craziest Moments From the Longest Tech Boom (So Far)

It’s been a singular year for tech, one that marked the apparent end to a heady, madcap boom that changed how we think about the industry.  Over the past dozen or so years, a tidal wave of money poure...

Opinion: 11 predictions for money, technology, stocks and crypto for 2023

Here are some 2023 predictions for financial markets, the economy and stocks. I’ve spent the last year and a half being cautious in the wake of the Bubble-Blowing Bull Market that finally ended early ...

ChatGPT is called ‘an iPhone moment in AI,’ but will it make money like the iPhone?

ChatGPT is the latest product of artificial intelligence to take away Silicon Valley’s breath (and venture-capital investments), but it is also yet another AI advancement that has not proved its abili...

Earn extra money with a side gig—here are 6 good ones for retirees

If inflation and the gyrating stock market has you fretting over your financial security in retirement, you’re not alone. Fully 71% of boomers recently surveyed by Bankrate said they are behind on ret...

Opinion: Microsoft invested in an AI system that helped me write this column about Tesla

Can an artificial intelligence system help me write articles about investment ideas? Let’s find out. There are two subjects I would like to cover. But I will have help, and as a result there is a thir...

Cloud software is suffering a cold November rain. Can Snowflake and Salesforce turn it around?

The week after Thanksgiving could determine if cloud software is still too fat or if there are some tasty leftovers for Wall Street. Autodesk Inc. ADSK, +1.82% signaled a slowdown in business spending...

Ray Dalio, Founder of Hedge Fund Giant Bridgewater, Sees More Pain Ahead

Ray Dalio founded Bridgewater Associates in his Manhattan apartment in 1975 and grew it into a hedge fund colossus—with about $150 billion in assets—through astute analysis of macroeconomic trends. Al...

Ray Dalio Sees More Pain Ahead in This Debt Cycle

Ray Dalio founded Bridgewater Associates in his Manhattan apartment in 1975 and grew it into a hedge fund colossus—with about $150 billion in assets—through astute analysis of macroeconomic trends. Al...

Argo Blockchain shares collapse as planned fundraising falls through

Argo Blockchain PLC shares fell Monday after it said it no longer expects to carry out a share subscription with a strategic investor, and warned it would need to complete further financing to avoid c...

Opinion: Stock market bulls have a new story to sell you. Don’t believe them — they’re just in the ‘bargaining’ stage of grief

Might the bear market’s losses at its recent low have gotten so bad that it was actually good news? Some eager stock bulls I monitor are advancing this convoluted rationale. The outline of their argum...

Intel earnings: Layoffs and margin pressure could overshadow Mobileye IPO

Intel Corp. must contend this week with an earnings report that notably lacked a formal pre-announcement, a bleaker-than-expected PC market and rumored layoffs, which will likely overshadow the initia...

Polestar Reported Strong EV Deliveries. Why the Stock Fell.

The latest delivery results from Polestar Automotive look solid, while the outlook for deliveries is even better. Investors seemed to be pleased before the September jobs number tanked the stock marke...

Chip stocks slammed by new ban on chip and AI technology for China

The chip sector melted down Friday after U.S. regulators moved to pump the brakes on China’s military ambitions by issuing new restrictions on semiconductor and AI technology that can be sold to the c...

‘Moore’s Law’s dead,’ Nvidia CEO Jensen says in justifying gaming-card price hike

Nvidia Corp. Chief Executive Jensen Huang on Wednesday said he thinks it’s going to be “a pretty terrific Q4 for Ada,” the company’s next-generation chip architecture unveiled this week, even as criti...

Nvidia’s ‘China Syndrome’: Is the stock melting down?

Like the nuclear reactor in the 1979 film “The China Syndrome,” Nvidia Corp.’s share price and sales forecast have been melting down, and a sales ban of artificial-intelligence chips to China is the l...